Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
In recent years, several associations between common chronic human disorders and altered gut microbiome composition and function have been reported. In most of these reports, treatment regimens were not controlled for and conclusions could thus be confounded by the effects of various drugs on the microbiota, which may obscure microbial causes, protective factors or diagnostically relevant signals. Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus (T2D). Two previous quantitative gut metagenomics studies of T2D patients that were unstratified for treatment yielded divergent conclusions regarding its associated gut microbial dysbiosis. Here we show, using 784 available human gut metagenomes, how antidiabetic medication confounds these results, and analyse in detail the effects of the most widely used antidiabetic drug metformin. We provide support for microbial mediation of the therapeutic effects of metformin through short-chain fatty acid production, as well as for potential microbiota-mediated mechanisms behind known intestinal adverse effects in the form of a relative increase in abundance of Escherichia species. Controlling for metformin treatment, we report a unified signature of gut microbiome shifts in T2D with a depletion of butyrate-producing taxa. These in turn cause functional microbiome shifts, in part alleviated by metformin-induced changes. Overall, the present study emphasizes the need to disentangle gut microbiota signatures of specific human diseases from those of medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“patient treatment with the drug metformin, a variable that subjects had not been stratified for previously, constituted the main determinant of microbial signatures in diabetic cohorts [62].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [62]
In the citing paper
“This action is an important determinant for the anti-hyperglycemic therapeutic effects, the gastrointestinal side effects and possibly the anti-aging effects of metformin (88, 89).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [88]
In the citing paper
“As for C. elegans, metformin use in humans will change the microbiome.”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [88]
In the citing paper
“Studies comparing individuals with T2D treated or not with metformin identified a higher level of E. coli and a lower level of Intestinibacter in the metformin-treated individuals, while confirming reduced levels of butyrate-producing bacteria such as Roseburia spp., F. prausnitzii, and unnamed Clostridiales in the untreated individuals compared to healthy controls5, 6, 34, 35.”
From The gut microbiome in atherosclerotic cardiovascular disease (2017) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
FLASH: fast length adjustment of short reads to improve genome assemblies
Magoč, T., & Salzberg, S. L. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr507 · Cited by 15,366
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W., & Godzik, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl158 · Cited by 11,410
VEGAN, a package of R functions for community ecology
Dixon, P. (2003) · Journal of Vegetation Science · doi:10.1111/j.1654-1103.2003.tb02228.x · Cited by 6,824
Cited by
Items 601–700 of 1,006
Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro
Breining, P., Jensen, J. B., Sundelin, E. I., Gormsen, L. C., Jakobsen, S., Busk, M., Rolighed, L., Bross, P., Fernandez‐Guerra, P., Markussen, L. K., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13362 · Cited by 60
A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis
Preez, S. D., Corbitt, M., Cabanas, H., Eaton-Fitch, N., Staines, D., & Marshall‐Gradisnik, S. (2018) · Systematic Reviews · doi:10.1186/s13643-018-0909-0 · Cited by 67
Essmann, C. L., Martínez‐Martínez, D., Pryor, R. E., Leung, K., Krishnan, K. B., Lui, P. P., Greene, N. D. E., Brown, A. E., Pawar, V., Srinivasan, M. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14785-0 · Cited by 67
Ma, W., Chen, J., Meng, Y., Yang, J., Cui, Q., & Zhou, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01336 · Cited by 64
Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer
Appunni, S., Rubens, M., Ramamoorthy, V., Saxena, A., Tonse, R., McGranaghan, P., Kaiser, A., & Kotecha, R. R. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.718389 · Cited by 68
Jin, H., Hu, G., Sun, C., Duan, Y., Zhang, Z., Liu, Z., Zhao, X., & Chen, W. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab973 · Cited by 66
Chen, K., Kortesniemi, M. K., Linderborg, K. M., & Yang, B. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05879 · Cited by 66
O'Toole, P. W., & Shiels, P. G. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13021 · Cited by 62
Ying, Y., Liu, S., Wang, Y., Wang, Z., Ding, W., Sun, X., He, K., Feng, Q., & Zhang, X. (2020) · Aging · doi:10.18632/aging.103399 · Cited by 67
Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population
Mammadova, G., Özkul, C., Işıkhan, S. Y., Açıkgöz, A., & Yıldız, B. O. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13417 · Cited by 66
Plichta, D. R., Somani, J., Pichaud, M., Wallace, Z. S., Fernandes, A. D., Perugino, C. A., Lähdesmäki, H., Stone, J. H., Vlamakis, H., Chung, D. C., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00853-7 · Cited by 59
Microbiota and Colorectal Cancer: From Gut to Bedside
Silva, M. G., Brunner, V., & Tschurtschenthaler, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.760280 · Cited by 66
Major Depressive Disorder and gut microbiota – Association not causation. A scoping review
Łoniewski, I., Misera, A., Skonieczna-Żydecka, K., Kaczmarczyk, M., Kaźmierczak-Siedlecka, K., Misiak, B., Marlicz, W., & Samochowiec, J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110111 · Cited by 61
Kamyshnyi, O., Matskevych, V. M., Lenchuk, T., Strilbytska, O. M., Storey, K. B., & Lushchak, O. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112230 · Cited by 66
MicroRNAs and the metabolic hallmarks of aging
Victoria, B., Nunez Lopez, Y. O., & Masternak, M. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.021 · Cited by 62
Gut Microbiota and Host Metabolism: What Relationship
Mithieux, G. (2018) · Neuroendocrinology · doi:10.1159/000484526 · Cited by 53
Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption
Hatton, G. B., Madla, C. M., Rabbie, S. C., & Basit, A. W. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.009 · Cited by 65
Li, H., Liu, B., Song, J., An, Z., Zeng, X., Li, J., Jiang, J., Xie, L., & Wu, W. (2019) · Microorganisms · doi:10.3390/microorganisms7100399 · Cited by 65
Self-citationPellanda, P., Ghosh, T. S., & O’Toole, P. W. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.11.001 · Cited by 65
New Insights Into the Anti-Diabetic Actions of Metformin: From the Liver to the Gut
Wu, T., Horowitz, M., & Rayner, C. K. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1273769 · Cited by 64
“in patients with type 2 diabetes favors short-chain fatty acid production for lowering blood glucose [73].”
Tierney, B. T., Tan, Y., Kostic, A. D., & Patel, C. J. (2021) · Nature Communications · doi:10.1038/s41467-021-23029-8 · Cited by 65
Structure, functions, and diversity of the healthy human microbiome
Ahrodia, T., Das, S., Bakshi, S., & Das, B. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.07.003 · Cited by 64
Ye, J., Wu, Z., Zhao, Y., Zhang, S., Liu, W.-T., & Su, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1029890 · Cited by 65
Interactions Between Antidepressants and Intestinal Microbiota
Xu, F., Xie, Q., Kuang, W., & Dong, Z. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01362-8 · Cited by 64
Xia, T., He, W., Luo, Z., Wang, K., & Tan, X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132256 · Cited by 64
Sieving through gut models of colonization resistance
Mullineaux-Sanders, C., Suez, J., Elinav, E., & Frankel, G. M. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0095-1 · Cited by 66
Effect of polysaccharides from adlay seed on anti-diabetic and gut microbiota
Chen, L.-C., Fan, Z.-Y., Wang, H.-Y., Wen, D.-C., & Zhang, S. (2019) · Food & Function · doi:10.1039/c9fo00406h · Cited by 64
Wakeman, M. P., & Archer, D. T. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s237454 · Cited by 65
Ejtahed, H.-S., Tito, R. Y., Siadat, S.-D., Hasani-Ranjbar, S., Hoseini-Tavassol, Z., Rymenans, L., Verbeke, K., Soroush, A.-R., Raes, J., & Larijani, B. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0826 · Cited by 63
Self-citationThe gut microbiome: an under-recognised contributor to the COVID-19 pandemic?
Segal, J. P., Mak, J. W. Y., Mullish, B. H., Alexander, J. L., Ng, S. C., & Marchesi, J. R. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820974914 · Cited by 64
Li, Z., Wang, X., Zhang, T., Si, H., Nan, W., Xu, C., Guan, L. L., Wright, A. G., & Li, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00004 · Cited by 63
Interaction of antidiabetic α‐glucosidase inhibitors and gut bacteria α‐glucosidase
Tan, K., Tesar, C., Wilton, R., Jedrzejczak, R. P., & Joachimiak, A. (2018) · Protein Science · doi:10.1002/pro.3444 · Cited by 63
Jaune, E., & Rocchi, S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00472 · Cited by 63
Kaur, G., Behl, T., BUNGAU, S. G., Kumar, A., Uddin, M. S., Mehta, V., Zengin, G., Mathew, B., Shah, M. A., & Arora, S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200606233050 · Cited by 64
Ke, Y., Lin, L., & Zhao, M. (2023) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2023.108870 · Cited by 62
Targeting AMPK for the Alleviation of Pathological Pain
Asiedu, M. N., Dussor, G. O., & Price, T. J. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_11 · Cited by 62
Cao, Y., Yao, G., Sheng, Y., Li, Y., Wang, Z., Yang, Z. Y., Zhuang, P., & Zhang, Y. (2019) · Journal of Diabetes Research · doi:10.1155/2019/1872134 · Cited by 62
The intestinal microbiota and cardiovascular disease
Katsimichas, T., Antonopoulos, A. S., Katsimichas, A., Ohtani, T., Sakata, Y., & Tousoulis, D. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz135 · Cited by 62
Comparative study on antidiabetic function of six legume crude polysaccharides
Bai, Z., Meng, J., Huang, X., Wu, G., Zuo, S., & Nie, S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.072 · Cited by 62
Peng, D., Tian, W., An, M., Chen, Y., Zeng, W., Zhu, S., Li, P., & Du, B. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.133974 · Cited by 62
Microbial evolution and ecological opportunity in the gut environment
Scanlan, P. D. (2019) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2019.1964 · Cited by 61
Byndloss, M. X., Devkota, S., Duca, F. A., Niess, J. H., Nieuwdorp, M., Orho‐Melander, M., Sanz, Y., Tremaroli, V., & Zhao, L. (2024) · Diabetologia · doi:10.1007/s00125-024-06198-1 · Cited by 62
Awata, T., Shimada, A., Maruyama, T., Oikawa, Y., Yasukawa, N., Kurihara, S., Miyashita, Y., Hatano, M., Ikegami, Y., Matsuda, M., et al. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0299-7 · Cited by 61
Wu, J., Li, K., Peng, W., Li, H., Li, Q., Wang, X., Peng, Y., Tang, X., & Fu, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105724 · Cited by 62
Context-Dependent Pharmacological Effects of Metformin on the Immune System
Marcucci, F., Romeo, E. L., Caserta, C. A., Rumio, C., & Lefoulon, F. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.003 · Cited by 61
Metformin effect on gut microbiota: insights for HIV-related inflammation
Ouyang, J., Isnard, S., Lin, J., Fombuena, B., Marette, A., Routy, B., Chen, Y., & Routy, J.-P. (2020) · AIDS Research and Therapy · doi:10.1186/s12981-020-00267-2 · Cited by 58
Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit
Ibrahim, S. M., Lowe, J. R., Bramante, C. T., Shah, S., Klatt, N. R., Sherwood, N. E., Aronne, L. J., Puskarich, M. A., Tamariz, L. J., Palacio, A., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.587801 · Cited by 61
Díaz-Perdigones, C. M., Muñoz‐Garach, A., Alvarez-Bermudez, M. D., Moreno‐Indias, I., & Tinahones, F. J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112448 · Cited by 61
Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment
Chen, H., Gong, J.-Y., Xing, K., Liu, M.-Z., Ren, H., & Luo, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.742394 · Cited by 61
Li, J., Si, H., Du, H., Guo, H., Dai, H., Xu, S., & Wan, J. (2021) · BMC Microbiology · doi:10.1186/s12866-020-02068-z · Cited by 60
Self-citationAlterations of the Gut Microbiota in Response to Total Sleep Deprivation and Recovery Sleep in Rats
Wang, Z., Yuan, K., Ji, Y.-B., Li, S.-X., Shi, L., Wang, Z., Zhou, X.-Y., Bao, Y.-P., Xie, W., Han, Y., et al. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s334985 · Cited by 60
Luo, H., Li, M., Wang, F., Yang, Y., Wang, Q. L., Zhao, Y., Du, F., Chen, Y., Shen, J., Zhao, Q., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72600 · Cited by 60
The hallmarks of dietary intervention-resilient gut microbiome
Klimenko, N. S., Odintsova, V. E., Revel-Muroz, A., & Tyakht, A. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00342-8 · Cited by 61
Zhang, Y., Liu, L., Wei, C., Wang, X., Li, R., Xu, X., Zhang, Y., Geng, G., Dang, K., Ming, Z., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02880-0 · Cited by 60
Dong, W., Fan, X., Guo, Y., Wang, S., Jia, S., Lv, N., Tao, Y., Pan, Y., Xue, Y., Chen, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51864-y · Cited by 60
Gut microbial metabolism in Alzheimer's disease and related dementias
Kang, J. W., Vemuganti, V., Kuehn, J. F., Ulland, T. K., Rey, F. E., & Bendlin, B. B. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00470 · Cited by 60
Predicting and Understanding the Human Microbiome’s Impact on Pharmacology
Hitchings, R., & Kelly, L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.04.014 · Cited by 61
The Use of Metformin to Increase the Human Healthspan
Piskovatska, V., Storey, K. B., Vaiserman, A. M., & Lushchak, O. V. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-42667-5_13 · Cited by 61
Quorum sensing: a new prospect for the management of antimicrobial-resistant infectious diseases
Haque, M., Islam, S., Sheikh, M. A., Dhingra, S., Uwambaye, P., Labricciosa, F. M., Iskandar, K., Charan, J., Abukabda, A. B., & Jahan, D. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1843427 · Cited by 60
Therdtatha, P., Song, Y., Tanaka, M., Mariyatun, M., Almunifah, M., Manurung, N. E. P., Indriarsih, S., Lu, Y., Nagata, K., Fukami, K., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9050897 · Cited by 60
Update on the gut microbiome in health and diseases
Salvadori, M., & Rosso, G. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i1.89196 · Cited by 59
Lung Microbiota and Its Impact on the Mucosal Immune Phenotype
Wu, B. G., & Segal, L. N. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0005-2016 · Cited by 61
Vinberg, M., Ottesen, N. M., Meluken, I., Sørensen, N., Pedersen, O. B., Kessing, L. V., & Miskowiak, K. W. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12976 · Cited by 60
Self-citationWakita, Y., Shimomura, Y., Kitada, Y., Yamamoto, H., Ohashi, Y., & Matsumoto, M. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1311-8 · Cited by 59
A Systems Approach to Refine Disease Taxonomy by Integrating Phenotypic and Molecular Networks
Zhou, X., Lei, L., Liu, J. H., Halu, A., Zhang, Y., Li, B., Guo, Z., Liu, G., Sun, C., Loscalzo, J., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.04.002 · Cited by 60
The Role of the Microbiome in Drug Response
Pryor, R. E., Martínez‐Martínez, D., Quintaneiro, L. M., & Cabreiro, F. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023612 · Cited by 59
Wang, S., Jiang, W., Ouyang, T., Shen, X.-Y., Wang, F., Qu, Y.-H., Zhang, M., Luo, T., & Wang, H.-Q. (2019) · Scientific Reports · doi:10.1038/s41598-019-56149-9 · Cited by 56
From nitrate to NO: potential effects of nitrate-reducing bacteria on systemic health and disease
Liu, H., Huang, Y., Huang, M., Wang, M., Ming, Y., Chen, W., Chen, Y., Tang, Z., & Jia, B. (2023) · European Journal of Medical Research · doi:10.1186/s40001-023-01413-y · Cited by 58
“Among these, the interaction of nitrate and biguanides with the host microbiota may be central to the underlying mechanism [225– 227].”
Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes
Caesar, R. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.01.007 · Cited by 58
Bai, Z., Huang, X., Wu, G., Zhang, Y. L., Xu, H., Chen, Y., Yang, H., & Nie, S. (2023) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2023.108670 · Cited by 58
Turjeman, S., Rozera, T., Elinav, E., Ianiro, G., & Koren, O. (2025) · Cell · doi:10.1016/j.cell.2025.01.038 · Cited by 58
Disruptive physiology: olfaction and the microbiome–gut–brain axis
Bienenstock, J., Kunze, W., & Forsythe, P. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12348 · Cited by 58
Roles of the gut microbiota in human neurodevelopment and adult brain disorders
Mallick, R., Basak, S., Das, R. K., Banerjee, A., Paul, S., Pathak, S., & Duttaroy, A. K. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1446700 · Cited by 58
From microbiome to metabolism: Bridging a two-decade translational gap
Hul, M. V., & Cani, P. D. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.011 · Cited by 57
Dujic, T., Zhou, K., Tavendale, R., Palmer, C. N. A., & Pearson, E. R. (2016) · Diabetes Care · doi:10.2337/dc16-0706 · Cited by 56
Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation
Cheru, L., Saylor, C. F., & Lo, J. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00332-6 · Cited by 57
Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health
Olsson, L. M., Poitou, C., Tremaroli, V., Coupaye, M., Aron‐Wisnewsky, J., Bäckhed, F., Clément, K., & Caesar, R. (2019) · Gut · doi:10.1136/gutjnl-2019-319322 · Cited by 58
The Microbiota and Gut-Related Disorders: Insights from Animal Models
Kamareddine, L., Najjar, H., Sohail, M. U., Abdulkader, H. A., & Al‐Asmakh, M. (2020) · Cells · doi:10.3390/cells9112401 · Cited by 57
Shapiro, H., Suez, J., & Elinav, E. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12501 · Cited by 56
Altered gut microbial metabolites could mediate the effects of risk factors in Covid‐19
Chen, J., Hall, S., & Vitetta, L. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2211 · Cited by 57
Ishii, C., Nakanishi, Y., Murakami, S., Nozu, R., Ueno, M., Hioki, K., Aw, W., Hirayama, A., Soga, T., Ito, M., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124079 · Cited by 56
The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation
Gibson, C. M., Childs‐Kean, L. M., Naziruddin, Z., & Howell, C. K. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13397 · Cited by 56
Kuka, J., Ozola, M., Makrecka‐Kuka, M., Liepiņš, J., Grīnberga, S., Sevostjanovs, E., Vilks, K., Liepinsh, E., & Dambrova, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-71470-4 · Cited by 56
Insights on β-glucan as a prebiotic coadjuvant in the treatment of diabetes mellitus: A review
Sivieri, K., de Oliveira, S. M., Marquez, A. D. S., Pérez‐Jiménez, J., & Diniz, S. N. (2022) · Food Hydrocolloids for Health · doi:10.1016/j.fhfh.2022.100056 · Cited by 56
Wee, J., Tan, X. R., Gunther, S. H., Ihsan, M., Leow, M. K., Tan, D. S., Eriksson, J. G., & LEE, J. K. W. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000782 · Cited by 55
Młynarska, E., Wasiak, J., Gajewska, A., Steć, G., Jasińska, J., Rysz, J., & Franczyk, B. (2024) · Nutrients · doi:10.3390/nu16121938 · Cited by 55
The Interplay between Immune System and Microbiota in Diabetes
Moffa, S., Mezza, T., CEFALO, C. M. A., Cinti, F., Impronta, F., Sorice, G. P., Santoro, A., Giuseppe, G. D., Pontecorvi, A., & Giaccari, A. (2019) · Mediators of Inflammation · doi:10.1155/2019/9367404 · Cited by 55
Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
Eibl, G., & Rozengurt, E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09977-z · Cited by 55
A data-driven approach for predicting the impact of drugs on the human microbiome
Algavi, Y. M., & Borenstein, E. (2023) · Nature Communications · doi:10.1038/s41467-023-39264-0 · Cited by 54
Biomarkers of adverse drug reactions
Carr, D. F., & Pirmohamed, M. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217733425 · Cited by 54
Park, J., Hosomi, K., Kawashima, H., Chen, Y.-A., Mohsen, A. S., Ohno, H., Konishi, K., Tanisawa, K., Kifushi, M., Kogawa, M., et al. (2022) · Nutrients · doi:10.3390/nu14102078 · Cited by 54
Sanjiwani, M. I. D., Aryadi, I. P. H., & Semadi, I. M. S. (2022) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.037.01.13 · Cited by 54
Wang, J., Zhang, H., Yuan, H., Chen, S., Yu, Y., Zhang, X., Gao, Z., Du, H., Li, W., Wang, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202307233 · Cited by 55
Self-citationRizo‐Roca, D., Henderson, J. D., & Zierath, J. R. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20090 · Cited by 55
The metabolism of a natural product mogroside V, in healthy and type 2 diabetic rats
Zhou, G., Zhang, Y., Li, Y., Wang, M., & Li, X. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.02.002 · Cited by 54
Gut microbiome and microbial metabolites: a new system affecting metabolic disorders
Federici, M. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01022-9 · Cited by 56
Shin, N. R., Gu, N., Choi, H. S., & Kim, H. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00221.2019 · Cited by 54
Cao, T. T. B., Wu, K., Hsu, J., Chang, C., Chou, C., Lin, C.-Y., Liao, Y.-M., Lin, P.-C., Yang, L., & Lin, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573891 · Cited by 54
Justice, J. N., Gubbi, S., Kulkarni, A. S., Bartley, J. M., Kuchel, G. A., & Barzilai, N. (2020) · GeroScience · doi:10.1007/s11357-020-00261-6 · Cited by 54
Rosell-Díaz, M., Petit-Gay, A., Molas-Prat, C., Gallardo‐Nuell, L., Ramió‐Torrentà, L., Garre‐Olmo, J., Pérez‐Brocal, V., Moyá, A., Jové, M., Pamplona, R., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155941 · Cited by 53
Metadata
- Authors
- MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Krogh Pedersen, H., Arumugam, M., Kristiansen, K., Yvonne Voigt, A., Vestergaard, H., Hercog, R., Igor Costea, P., Roat Kultima, J., Li, J., Jørgensen, T., Levenez, F., Dore, J., Bjørn Nielsen, H., Brunak, S., Raes, J., Hansen, T., Wang, J., Dusko Ehrlich, S., Bork, P., & Pedersen, O.
- Affiliations
- Vrije Universiteit Brussel (BE)
- University of Copenhagen (DK)
- Rega Institute for Medical Research (BE)
- European Molecular Biology Laboratory (DE)
- Microbiologie de l’alimentation au service de la santé (FR)
- BGI Group (China) (CN)
- Corresponding author
- Pedersen, Oluf
- ORCID
- Venue
- Nature
- Published
- 2015-12-02
- Volume
- 528
- Issue
- 7581
- Pages
- 262-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4681099
- OpenAlex
- W2188930066
- Cited by
- 2,116
- References
- 49
- Citations by year
- 2026: 113 · 2025: 167 · 2024: 212 · 2023: 194 · 2022: 253 · 2021: 270 · 2020: 256 · 2019: 185 · 2018: 197 · 2017: 150 · 2016: 112 · 2015: 3
- FWCI
- 66.83
- Type
- journal article
- Language
- en
- Update notices
- erratum (2017-05-04)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Innovationsfonden
- European Molecular Biology Laboratory
- European Commission (600375, 2007–2013, FP7 2007-2013, HORIZON2020, FP7/2007, 305312, 201052, 261376)
- Agence Nationale de la Recherche (ANR-11-DPBS-0001)
- Lundbeckfonden
- Novo Nordisk
- Göteborgs Universitet
- Copenhagen Graduate School for Nanoscience and Nanotechnology
- Novo Nordisk Foundation Center for Basic Metabolic Research
- H. Lundbeck A/S
- FP7 Ideas: European Research Council (268985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- type 2 diabetes, gut microbiota, metformin, antidiabetic drugs, dysbiosis, confounding by treatment, short-chain fatty acids, butyrate, Escherichia, metagenome-wide association study
- MeSH terms
- Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Male, Metformin, RNA, Ribosomal, 16S, Biodiversity, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.